Claimant seeks judicial review of an order of the Workers’ Compensation Board
The statutory provisions at the center of this case require that, in order to receive workers’ compensation for medical treatment of a disease, a worker “must prove that employment conditions were the major contributing cause” of the need for that treatment. ORS 656.802(2)(a). Thus, if the major contributing cause is a preexisting condition that is not related to employment, the treatment is not compensable. However — and here lies the dispute — if a preexisting condition “merely renders the worker more susceptible” to the disease that needs treatment, as opposed to causing it, then that preexisting condition does not contribute to the need for treatment. ORS 656.005(24)(c) (emphasis added); Multnomah County v. Obie,
The relevant facts are few and, on judicial review, undisputed. Claimant worked for Sherman Brothers Trucking as a lube technician and, for safety reasons, wore steel-toed boots while working. The boots caused him to develop a blister on his right great toe. The blister became infected, and the infection ultimately led to the need for amputation of the toe.
Claimant has diabetes. As one aspect of that condition, he had a progressive loss of sensory perception in his extremities, including his right foot. That loss of sensory perception is known as diabetic neuropathy. According to claimant’s attending physician, Dr. Bourne, claimant’s diabetic neuropathy “made it less likely that [claimant] would notice the progressive infection ulcer until it was quite advanced.” That delay, in turn, resulted in the need for amputation. In Bourne’s opinion, diabetic neuropathy “contributed to [the infection’s] severity but did not cause the infection independently. Diabetes is not an infectious disease.”
A different physician, Dr. Landry, whose opinion the board found to be more persuasive than Bourne’s, reported that, in addition to the diabetic neuropathy, another aspect of diabetes, microvascular disease, was a factor in the infection and need for amputation. Landry acknowledged that one way that claimant’s diabetic neuropathy contributed to the severity of the infection was because of the lack of sensation in his foot, which caused him not to notice the infection until it was fairly advanced. He explained that “[t]his is something we see very frequently in people with diabetes and diabetic neu-ropathy, that they develop small foot lesions that lead to significantly bigger problems than in someone who didn’t have diabetes” because “people with normal sensation in their foot are more aware of problems before and as they arise than people with diabetic neuropathy.” He also explained that “people with diabetes have what we call microvascular disease, so that oftentimes * * * they’re not able to mount as strong of a response to these types of insults and these types of infections.” Landry concluded that “the major contributing cause of [claimant’s] condition was the diabetes and diabetic neuropathy.”
We note preliminarily that the different physicians’ characterizations of the sequence of events leading to the need for amputation are of limited relevance. The medical facts on review are: first, claimant had diabetes and, along with it, microvascular disease and diabetic neuropathy; and second, without those conditions, claimant’s blister would not have become so severely infected as to require amputation. Whether that factual sequence of events fits within the statutory exception to contributory causation in ORS 656.005(24)(c) — mere susceptibility — is a legal question involving statutory interpretation. See Young v. Hermiston,
We have already held, under similar medical facts, that diabetic neuropathy is a predisposition and not a contributing cause. In Portland Adventist Medical Center v. Buckallew,
SAIF does not disagree. Rather, it argues that the aspect of claimant’s diabetic condition that resulted in the amputation was not merely neuropathy, but also, as Landry asserted, microvascular disease. Even assuming that the evidence supports SAIF’s argument that claimant had micro-vascular disease, the evidence shows that microvascular disease did not, as SAIF claims, “contribute[ ] to the occurrence of the skin lesion in the foot that led to the infection and ultimately to the * * * amputation.” Rather, Landry’s testimony indicates only that microvascular disease, in his words, renders a patient “[un\able to mount as strong of a response to these types of insults and these types of infections.” (Emphasis added.) We cannot conceive of a more succinct example of “merely rendering]” a person “more susceptible” than rendering the person “[un]able to mount as strong of a response.” See Webster’s Third New Int’l Dictionary 2303 (unabridged ed 2002) (defining “susceptible” to mean, among other things, “having little resistence to a specific infectious disease”).
Thus, the board’s conclusion that claimant’s diabetes and diabetic neuropathy were the major contributing cause of his
Reversed and remanded.
